← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2000Last known activity
Jan 31, 2025
Timeline
1970s
- May 28, 1970
Juvenile Diabetes Research Foundation— Founded
Drugs by trial phase (97 distinct, 123 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (19 own, 0 via acquisition)
Phase 2 (52 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Indications
Studied for
- Autoimmune Diseases
- Coronary Artery Disease
- Coronary Disease
- Diabetes Mellitus
- Diabetes Mellitus, Experimental
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Diabetic Neuropathies
- Diabetic Retinopathy
- Edema
- Glucose Intolerance
- Hyperglycemia
- Hypoglycemia
- Inflammation
- Insulin Resistance
- Kidney Diseases
- Macular Edema
- Myocardial Ischemia
- Overweight
- Polyneuropathies
- Retinal Diseases
Recent trials (50)
- NCT06435156CollaboratorPhase 2Jan 31, 2025
- NCT06072326CollaboratorPhase 2Mar 31, 2024
- NCT06305286CollaboratorPhase 1/Phase 2Mar 4, 2024
- NCT06147232CollaboratorPhase 4Feb 29, 2024
- NCT06046417CollaboratorPhase 2/Phase 3Nov 30, 2023
- NCT05822609CollaboratorPhase 2Nov 30, 2023
- NCT05904028CollaboratorPhase 3Nov 9, 2023
- NCT05949281CollaboratorPhase 2Aug 29, 2023
- NCT05768191CollaboratorPhase 4Jun 15, 2023
- NCT05696366CollaboratorPhase 1/Phase 2Feb 28, 2023
- NCT05742243CollaboratorPhase 2Feb 13, 2023
- NCT05537233CollaboratorPhase 2Jan 1, 2023
- NCT05594563CollaboratorPhase 2Dec 31, 2022
- NCT05473364CollaboratorPhase 1/Phase 2Dec 1, 2022
- NCT05349591CollaboratorPhase 1Aug 15, 2022
Details
- Founded
- New York, NY, US May 28, 1970
- Last known activity
- Jan 31, 2025